Optimizing Gastroenterology Availity Integration for Prior Authorization

Effective **gastroenterology Availity integration** is critical for managing the high volume and complexity of prior authorizations for GI biologics, advanced imaging, and endoscopic procedures. Klivira streamlines these workflows by leveraging Availity's multi-payer connectivity.

Gastroenterology practices face a significant administrative burden from prior authorizations, particularly for chronic conditions like IBD and complex diagnostic procedures. Navigating diverse payer requirements through individual portals or manual processes is time-intensive and prone to errors. Integrating with a multi-payer clearinghouse like Availity is essential for consolidating these interactions and enhancing efficiency.

The Challenge of GI Prior Authorizations with Multi-Payer Portals

Gastroenterology prior authorizations are characterized by high volumes of specialty drugs, particularly IBD biologics such as Humira, Stelara, Skyrizi, and Entyvio, alongside frequent procedures and advanced imaging. Each payer often presents unique medical necessity criteria, step therapy requirements, and documentation demands, making manual submission through various portals inefficient. Availity, as a multi-payer clearinghouse, centralizes access to many major commercial payers, but manual data entry into Availity Essentials still consumes valuable staff time and can introduce delays.

Key Gastroenterology PA Triggers Managed via Availity

**IBD Biologics:** Chronic treatment for Crohn's and Ulcerative Colitis (e.g., infliximab, adalimumab, ustekinumab, vedolizumab), requiring periodic re-authorization and adherence to step therapy protocols.
**Hepatitis C Direct-Acting Antivirals:** Agents like sofosbuvir-velpatasvir and glecaprevir-pibrentasvir, with pathways differing based on treatment-naive vs. treatment-experienced status.
**Advanced Imaging:** MRCP, MR enterography, CT enterography for IBD assessment, often requiring detailed clinical justification.
**Endoscopic Procedures:** Capsule endoscopy (CPT 91110), small-bowel enteroscopy, ERCP, and EUS for specific diagnostic and therapeutic indications.
**Specialty Drugs for Functional GI Disorders:** Medications such as eluxadoline for IBS-D or linaclotide for IBS-C/CIC, often requiring documentation of prior conservative therapy trials.

Klivira's Automated Approach to Gastroenterology Availity Integration

Klivira's platform automates the submission and tracking of GI prior authorizations by integrating directly with your EMR and leveraging Availity's robust multi-payer connectivity. This eliminates manual data entry into Availity Essentials, ensuring that required clinical documentation—such as disease severity (Mayo score, CDAI), prior conventional therapy trials, and TB/hepatitis screenings for biologics—is accurately transmitted. Our system incorporates ACG, AGA, and AASLD guideline-aware logic to pre-validate submissions against payer policies before they reach Availity, significantly reducing initial denials.

Addressing Common GI Prior Authorization Denial Reasons

**Step Therapy Non-Compliance:** Automated adherence to payer-specific step therapy protocols for IBD biologics, including requirements for conventional therapy trials or TNF inhibitor sequencing.
**Biosimilar Substitution:** Intelligent routing and alerts for biosimilar mandates, preventing denials for brand TNF inhibitors when a biosimilar is required first.
**Missing Documentation:** Proactive identification and flagging of absent critical information, such as disease severity scores or necessary pre-biologic screenings.
**Treatment-Status Misclassification:** Accurate classification of treatment-naive vs. treatment-experienced patients for Hep C DAAs and IBD biologics, a common source of denials.
**Inadequate Clinical Justification:** Ensuring advanced imaging and endoscopic procedure requests include all necessary clinical correlation and prior workup details per payer policy.

Streamlining GI Workflow: From EMR to Availity and Beyond

Our integration facilitates a seamless workflow from order placement in your EMR to prior authorization submission via Availity. Klivira interprets order types and clinical templates to identify PA triggers, then automatically populates the necessary forms for submission through Availity's X12 278 or ePA channels. This includes managing the complexities of chronic-treatment re-authorizations for IBD biologics and intelligently routing for medical vs. pharmacy benefit considerations, ensuring continuous patient access to critical therapies while reducing administrative overhead.

Frequently asked questions

How does Klivira handle the medical vs. pharmacy benefit split for GI biologics when integrating with Availity?

Klivira's platform intelligently identifies whether a biologic agent, such as an IBD medication, falls under the medical or pharmacy benefit based on its administration mode and payer rules. It then routes the prior authorization request through the appropriate Availity channel (e.g., X12 278 for medical benefit, or potentially NCPDP SCRIPT for pharmacy benefit if supported by the payer via Availity) to ensure correct processing and reduce delays.

Can Klivira's Availity integration help with re-authorizations for chronic GI conditions?

Yes, Klivira specifically supports periodic re-authorization workflows for chronic GI treatments, such as IBD biologics. Our system tracks re-authorization cadences and prompts for updated clinical documentation, like ongoing disease response, to facilitate timely submissions through Availity, minimizing treatment interruptions for patients.

What EMR touchpoints are supported by Klivira for gastroenterology Availity integration?

Klivira integrates with common EMR systems using standards like SMART on FHIR where available, or other API/interface technologies. This allows us to extract relevant clinical data directly from order types, progress notes, and medication histories within your EMR, automatically populating prior authorization requests before submission to payers via Availity.

How does Klivira ensure compliance with specific GI clinical guidelines like ACG or AGA when using Availity?

Klivira embeds payer-specific policy logic that is informed by major clinical guidelines from bodies like ACG, AGA, and AASLD. Before submitting a prior authorization request through Availity, our system pre-validates the documentation against these criteria, flagging any missing information or non-compliance with step therapy rules, thereby increasing the likelihood of approval.

Does Klivira's Availity integration support all types of GI procedures and advanced imaging?

Klivira's platform is designed to support a broad range of GI procedures and advanced imaging that require prior authorization. This includes complex endoscopic procedures like capsule endoscopy, ERCP, EUS, and advanced abdominal imaging such as MRCP or CT enterography. By leveraging Availity's multi-payer reach, we ensure these requests are submitted with the correct clinical justification and documentation to meet diverse payer requirements.